-
1
-
-
77953961244
-
Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer
-
doi:10.1016/j.radonc.2010.02.010
-
Pinkawa M, Piroth MD, Holy R et al (2010) Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer. Radiother Oncol 96: 25-29. doi: 10. 1016/j. radonc. 2010. 02. 010.
-
(2010)
Radiother Oncol
, vol.96
, pp. 25-29
-
-
Pinkawa, M.1
Piroth, M.D.2
Holy, R.3
-
2
-
-
33745184874
-
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference
-
doi:10.1016/j.ijrobp.2006.04.029
-
Roach M III, Hanks G, Thames H Jr et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65: 965-974. doi: 10. 1016/j. ijrobp. 2006. 04. 029.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 965-974
-
-
Roach III, M.1
Hanks, G.2
Thames Jr., H.3
-
3
-
-
30544454901
-
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time
-
doi:10.1016/j.ijrobp.2006.04.029
-
Ciezki JP, Reddy CA, Garcia J et al (2006) PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time. Int J Radiat Oncol Biol Phys 64: 512-517. doi: 10. 1016/j. ijrobp. 2006. 04. 029.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 512-517
-
-
Ciezki, J.P.1
Reddy, C.A.2
Garcia, J.3
-
4
-
-
84861097286
-
PSA Nadir of <0.5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure
-
doi:10.1016/j.ijrobp.2011.07.009
-
Ko EC, Stone NN, Stock RG (2012) PSA Nadir of < 0. 5 ng/mL following brachytherapy for early-stage prostate adenocarcinoma is associated with freedom from prostate-specific antigen failure. Int J Radiat Oncol Biol Phys 83: 600-607. doi: 10. 1016/j. ijrobp. 2011. 07. 009.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.83
, pp. 600-607
-
-
Ko, E.C.1
Stone, N.N.2
Stock, R.G.3
-
5
-
-
34548497179
-
PSA kinetics and PSA bounce following permanent seed prostate brachytherapy
-
doi:10.1016/j.ijrobp.2007.03.031
-
Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G (2007) PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Int J Radiat Oncol Biol Phys 69: 426-433. doi: 10. 1016/j. ijrobp. 2007. 03. 031.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
, pp. 426-433
-
-
Crook, J.1
Gillan, C.2
Yeung, I.3
Austen, L.4
McLean, M.5
Lockwood, G.6
-
6
-
-
33644559978
-
PSA nadir predicts biochemical and distant failures after External Beam radiotherapy for prostate cancer: a multi-institutional analysis
-
doi:10.1016/j.ijrobp.2005.07.006
-
Ray ME, Thames HD, Levy LB et al (2006) PSA nadir predicts biochemical and distant failures after External Beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Onc Biol Phys 64: 1140-1150. doi: 10. 1016/j. ijrobp. 2005. 07. 006.
-
(2006)
Int J Radiat Onc Biol Phys
, vol.64
, pp. 1140-1150
-
-
Ray, M.E.1
Thames, H.D.2
Levy, L.B.3
-
7
-
-
0033253970
-
Post-treatment PSA ≤ 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques
-
doi:10.1016/S0090-4295(99)00346-5
-
Critz FA, Williams WH, Holladay CT et al (1999) Post-treatment PSA ≤ 0. 2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques. Urology 54: 968-971. doi: 10. 1016/S0090-4295(99)00346-5.
-
(1999)
Urology
, vol.54
, pp. 968-971
-
-
Critz, F.A.1
Williams, W.H.2
Holladay, C.T.3
-
8
-
-
0035450305
-
10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy
-
doi:10.1016/S0360-3016(01)01601-7
-
Grimm PD, Blasko JC, Sylvester JE, Meier RM, Cavanagh W (2001) 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy. Int J Radiat Oncol Biol Phys 51: 31-40. doi: 10. 1016/S0360-3016(01)01601-7.
-
(2001)
Int J Radiat Oncol Biol Phys
, vol.51
, pp. 31-40
-
-
Grimm, P.D.1
Blasko, J.C.2
Sylvester, J.E.3
Meier, R.M.4
Cavanagh, W.5
-
9
-
-
45849091883
-
Analysis of prostate-specific antigen bounce after I(125) permanent seeds implant for localized prostate cancer
-
doi:10.1016/j.radonc.2008.04.004
-
Mitchell DM, Swindell R, Elliott T et al (2008) Analysis of prostate-specific antigen bounce after I(125) permanent seeds implant for localized prostate cancer. Radiother Oncol 88: 102-107. doi: 10. 1016/j. radonc. 2008. 04. 004.
-
(2008)
Radiother Oncol
, vol.88
, pp. 102-107
-
-
Mitchell, D.M.1
Swindell, R.2
Elliott, T.3
-
10
-
-
0742272178
-
PSA bounce predicts early success in patients with permanent iodine-125 prostate implant
-
doi:10.1016/j.urology.2003.08.025
-
Patel C, Elshaikh MA, Angermeier K et al (2004) PSA bounce predicts early success in patients with permanent iodine-125 prostate implant. Urology 63: 110-113. doi: 10. 1016/j. urology. 2003. 08. 025.
-
(2004)
Urology
, vol.63
, pp. 110-113
-
-
Patel, C.1
Elshaikh, M.A.2
Angermeier, K.3
-
11
-
-
0038300427
-
Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications
-
doi:10.1016/S0360-3016(02)04470-X
-
Stock RG, Stone NN, Cesaretti JA (2003) Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications. Int J Radiat Oncol Biol Phys 56: 448-453. doi: 10. 1016/S0360-3016(02)04470-X.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.56
, pp. 448-453
-
-
Stock, R.G.1
Stone, N.N.2
Cesaretti, J.A.3
-
12
-
-
0141954161
-
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age
-
doi:10.1097/01.ju.0000091644.41330.2a
-
Critz FA, Williams WH, Levinson AK et al (2003) Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. J Urol 170: 1864-1867. doi: 10. 1097/01. ju. 0000091644. 41330. 2a.
-
(2003)
J Urol
, vol.170
, pp. 1864-1867
-
-
Critz, F.A.1
Williams, W.H.2
Levinson, A.K.3
-
13
-
-
63449113150
-
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis
-
doi:10.1111/j.1464-410X.2008.08234.x
-
Satoh T, Ishiyama H, Matsumoto K et al (2009) Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis. BJU Int 103: 1064-1068. doi: 10. 1111/j. 1464-410X. 2008. 08234. x.
-
(2009)
BJU Int
, vol.103
, pp. 1064-1068
-
-
Satoh, T.1
Ishiyama, H.2
Matsumoto, K.3
-
14
-
-
78649982899
-
Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy-an Australian analysis
-
doi:10.1016/j.ijrobp.2009.10.016
-
Zwahlen DR, Smith R, Andrianopoulos N, Matheson B, Royce P, Millar JL (2011) Prostate-specific antigen bounce after permanent iodine-125 prostate brachytherapy-an Australian analysis. Int J Radiat Oncol Biol Phys 79: 179-187. doi: 10. 1016/j. ijrobp. 2009. 10. 016.
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.79
, pp. 179-187
-
-
Zwahlen, D.R.1
Smith, R.2
Andrianopoulos, N.3
Matheson, B.4
Royce, P.5
Millar, J.L.6
-
15
-
-
70849085514
-
Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon
-
doi:10.1016/j.urology.2009.01.043
-
Caloglu M, Ciezki J (2009) Prostate-specific antigen bounce after prostate brachytherapy: review of a confusing phenomenon. Urology 74: 1183-1190. doi: 10. 1016/j. urology. 2009. 01. 043.
-
(2009)
Urology
, vol.74
, pp. 1183-1190
-
-
Caloglu, M.1
Ciezki, J.2
-
16
-
-
84856233701
-
Outcomes after prostate brachytherapy are even better than predicted
-
doi:10.1002/cncr.26307
-
Frank SJ, Levy LB, van Vulpen M et al (2012) Outcomes after prostate brachytherapy are even better than predicted. Cancer 118: 839-847. doi: 10. 1002/cncr. 26307.
-
(2012)
Cancer
, vol.118
, pp. 839-847
-
-
Frank, S.J.1
Levy, L.B.2
van Vulpen, M.3
|